Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes
Daniel Edmonston(Duke University), Neha J. Pagidipati(Duke University), W. Schuyler Jones(Duke University), Hillary Mulder(Clinical Research Institute), Ashley Goss(Boehringer Ingelheim (United States)), Kelly J. Hunt(Medical University of South Carolina), Wenke Hwang(Penn State Milton S. Hershey Medical Center), Keith Marsolo(University of Cincinnati), Raj C. Shah, Javed Butler(Jackson Memorial Hospital), Hayden B. Bosworth(Durham VA Health Care System), Alex R. Chang, Vivian Fonesca(Tulane University), Daniel Fort(Ochsner Health System), Faraz S. Ahmad(Northwestern University), Ajaykumar Rao(Temple University), Adriana M. Hung(Nashville Oncology Associates), Elizabeth Lydon(Duke University), Daniel E. Ford(Johns Hopkins University), Isabelle Ayoub(The Ohio State University Wexner Medical Center), Howard S. Gordon(University of Illinois Chicago), Sriram Machineni, Zachary Lampron(Duke University), Max Pitlosh(Rush University Medical Center), Karen Chiswell(Amyloidosis Foundation)
Cited by 27
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
|Circulation|2020|9.4k
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
|Circulation|2019|9.1k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k